Epstein-Barr virus (EBV) — is a double-stranded, DNA-containing gamma-herpesvirus that infects approximately 95% of the world's population. Almost all people reading this are latently infected with EBV… So can EBV harm us? The answer is usually no. Many people become infected with EBV as young children but have no symptoms. If you happen to be initially exposed to EBV as a teenager (typically through saliva), your body can mount a benign immune response known as infectious mononucleosis or "mono". This is why EBV is known as "The Kissing Disease"! Almost all people recover from mono with no complications and will never have it again, but they will still have EBV DNA in a small percentage of their white blood cells. This life-long infection in which progeny virus is not made is what we mean by "latency".


An electron microscope image of Epstein Barr Virus. EBV virion particles are approximately 150 nanometers in diameter. That's about 1/1000th of the diameter of a human hair!

(Image from the National Cancer Institute)

So then why study EBV?! Interestingly, EBV was first discovered in association with a common African childhood tumor, Burkitt Lymphoma. It was the first human "cancer-causing" or oncogenic virus discovered and since that time, EBV has been attributed causally to more than 200,000 cancer cases per year, including:


                                Hodgkin’s Lymphoma

                                Burkitt Lymphoma

                                Diffuse Large B-Cell Lymphoma

                                Primary Effusion Lymphoma

                                Post-Transplant Lymphoproliferative Disorder

                                Nasopharyngeal carcinoma

                                Gastric carcinoma

                                Oral hairy leukoplakia



Many of these cancers attributed to EBV occur in immunocompromised people. These cancers arise in people a few years after to decades after being first infected with EBV.


In our lab, we investigate many different facets of EBV, including its latent infection and transforming capabilities in B cells, its escape from latency and viral production, as well as interactions with other viruses such as Kaposi's Sarcoma-associated Herpesvirus (KSHV). Our group studies EBV and KSHV both to understand their molecular contributions to cancers they cause and to develop rational means to treat them.


Please see our research tab for more information about our work with the original human tumor virus!


Want to know more about the cancer research done at McArdle Laboratory? Click here for a video from Wednesday Night at the Lab where Bill talks about "How McArdle Scientists Uncovered the Causes of Cancer".